medigraphic.com
ISSN 1561-3119 (Electronic)

2013, Number 3

<< Back Next >>

Rev Cubana Pediatr 2013; 85 (3)

Lipid impairments in the essential blood hypertension

LLapur MR,González SR, Borges AK, Rubio ODY

Language: Spanish
References: 25
Page:
PDF size: 143.77 Kb.


ABSTRACT

Introduction: child blood hypertension has increased throughout the years due to inadequate lifestyles and has been accompanied by other comorbidities including dyslipidemias.
Objective: to determine the frequency of dyslipidemias in children and adolescents suffering essential blood hypertension and its relationship with other cardiovascular risk factors.
Methods: a cross-sectional descriptive study, which used demographic, anthropometric and biochemical variables, was conducted. The universe of study was 100 children and adolescents aged 4 to 18 years old, who had been seen at the blood hypertension service of the pediatric hospital in Centro Habana municipality in the period of January 2009 through December 2010.
Results: it was found that 7 % of children had high cholesterol values, 6 % presented with risk factors and 9 % with high triglyceride figures, being more frequent in the 10- 14 y age group, followed by 15-18 y group. All the children with high cholesterol values had family histories of blood hypertension and dyslipidemia as well as 83.3 % had diabetes antecedents, with no significant difference among the groups, except for dyslipidemia. No relationship was found between family histories and triglyceride values whereas cholesterol was significantly associated with obesity in children.
Conclusions: dyslipidemia accounted for almost 20 % of studied children and hypercholesterolemia was related to family history of dyslipidemia and child obesity.


REFERENCES

  1. Magnussen CG, Raitakari Ol. Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood. Circulation. 2008;117:32-42.

  2. Boneparth A, Flynn JT. Evaluation and Treatment of Hypertension. Gen Ped Pract. 2009;48(1):44-9.

  3. McCrindle BW. Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents. Circulation. 2007;115:1948-67.

  4. Daniels S, Creer F and the Committee on Nutrition Lipid. Screening and cardiovascular health in childhood. Pediatrics. 2008;122(1):198-208.

  5. Capman MJ, Sposito AC. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy. Pharmacol Ther. 2008;117(3):354-73.

  6. Nasiff Hadad, Pérez A, Pérez LM. Primer consenso nacional de dislipoproteinemias. Guía para la prevención, detección, diagnóstico y tratamiento; 2005.

  7. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics. 2004;14(2):555-76.

  8. Mellina Ramírez E, González Montero A, Moreno del Sol JA, Jiménez Paneque R, Peraza Roque G. Factores de riesgo asociados a la hipertensión arterial en adolescentes. Rev Cubana Med Gen Integr [serie en Internet]. 2001 [citado 4 de noviembre de 2006];17(5). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 21252001000500005&lng=es&nrm=iso&tlng=es

  9. Cabal Giner MA, Hernández Oviedo G, Torres Díaz G, Guerra Marín M. Alteraciones del estado nutricional y la tensión arterial como señales tempranas de aterosclerosis en adolescentes. Rev Cubana Med Gen Integr [serie en Internet]. 2010 [citado 10 de septiembre de 2011];26(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 21252010000200005&lng=es&nrm=iso&tlng=es

  10. Llapur Milián R, González Sánchez R. Comportamiento de los factores de riesgo cardiovascular en niños y adolescentes con hipertensión arterial esencial. Rev Cubana Pediatr [serie en Internet]. 2006 [citado 7 de julio de 2010];78(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75312006000100007&lng=es&nrm=iso&tlng=es

  11. Pinto A, Roldan R, Sollecito TP. Hypertension in Children: an overview. J Dent Educ. 2006;70(4):434-40.

  12. Maggio AB, Aggoun Y, Marchand LM, Martin XE, Herrmann F, Beghetti M, et al. Associations among obesity, blood pressure, and left ventricular mass. J Pediatr. 2008;152(4):489-93.

  13. Marcano M, Solano L, Pontiles M. Prevalencia de hiperlipidemia e hiperglicemia en niños obesos ¿riesgo aumentado de enfermedad cardiovascular? Nutr Hosp [serie en Internet]. 2006 [citado 7 de julio de 2010];21(4). Disponible en:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212- 16112006000700005&lng=es&nrm=iso&tlng=es

  14. Monge-Rojas R. Serum lipids and lipoprotein levels in Costa Rican 13-18 year-old teenagers. Arch Latinoam Nutr. 2007;51:236-43.

  15. Garcés C, de Oya M. Factores de riesgo cardiovascular en la edad infantil. Resultados globales del estudio cuatro provincias. Rev Esp Cardiol. 2007;60(5):30-89.

  16. Aguilar G, Canela J. Hipercolesterolemia en niños ¿un problema real? Rev Mex Patol Clin. 2008;55(2):59-65.

  17. Roseann T. Spiott A, Gregory B. Evaluating Obesity and Cardiovascular Risk Factors in Children and Adolescents. Am Fam Physician. 2008;78(9):1052-8.

  18. McGil Hl, McMahan A, Gidding S. Preventing Heart Disease in the 21st Century Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study. Circulation. 2008;117:1216-27.

  19. Ferrer Arrocha M, García M, Nario OG. Factores de riesgo aterogénico en adolescentes de secundaria básica. Rev Cubana Pediatr [serie en Internet]. 2008 [citado 7 de julio de 2010];82(4). Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75312008000200002&lng=es&nrm=iso.&tlng=es

  20. McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007;115:1948- 67.

  21. González SR, Llapur Milián R. Hipertensión arterial en adolescentes y riesgo cardiovascular. CD IV Simposio Internacional de Hipertensión Arterial, 2008.

  22. Steinberger J, Daniels S, Eckel R, Hayman L, Lustig R, McCrindle B, et al. Progress and Challenges in Metabolic Syndrome in Children and Adolescents. Circulation. 2009;119:628-47.

  23. Douglas R, Obarzanek E, Franko D, Barton B, Morrison J, Biro F, et al. Childhood overweight and cardiovascular disease risk factors: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr. 2007;150(1):18-25.

  24. Gillian S, Gidding S, Falkner B, Koenigsberg J. Effects of obesity on high blood pressure on plasma lipid levels in children and adolescent. Pediatrics. 2004;114(6):1534-44.

  25. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report November 14; 2011. Pediatrics. 2011;128(Supl):5213-24.




2020     |     www.medigraphic.com